Tilray Brands Inc (TLRY)
1.84
+0.12
(+6.98%)
USD |
NASDAQ |
Apr 23, 16:00
1.83
-0.01
(-0.54%)
After-Hours: 07:34
Tilray Brands Cash from Investing (TTM): 75.71M for Feb. 29, 2024
Cash from Investing (TTM) Chart
Historical Cash from Investing (TTM) Data
Date | Value |
---|---|
February 29, 2024 | 75.71M |
November 30, 2023 | 43.03M |
August 31, 2023 | -309.86M |
May 31, 2023 | -285.11M |
February 28, 2023 | -282.44M |
November 30, 2022 | -278.88M |
August 31, 2022 | -14.45M |
May 31, 2022 | -21.53M |
February 28, 2022 | 332.57M |
November 30, 2021 | 325.08M |
August 31, 2021 | 51.18M |
May 31, 2021 | 46.10M |
February 28, 2021 | -304.35M |
November 30, 2020 | -316.72M |
August 31, 2020 | -32.67M |
May 31, 2020 | -69.95M |
February 29, 2020 | -55.50M |
November 30, 2019 | -56.84M |
August 31, 2019 | -158.11M |
May 31, 2019 | -134.52M |
February 28, 2019 | -184.20M |
November 30, 2018 | -256.49M |
August 31, 2018 | -168.14M |
May 31, 2018 | -171.29M |
Date | Value |
---|---|
February 28, 2018 | -216.31M |
November 30, 2017 | -176.99M |
August 31, 2017 | -174.20M |
May 31, 2017 | -149.96M |
February 28, 2017 | -70.02M |
November 30, 2016 | -15.69M |
August 31, 2016 | -9.812M |
May 31, 2016 | -4.578M |
February 29, 2016 | |
November 30, 2015 | |
August 31, 2015 | |
May 31, 2015 | |
February 28, 2015 | |
November 30, 2014 | 0.2105M |
August 31, 2014 | 0.1058M |
May 31, 2014 | 0.0321M |
February 28, 2014 | 0.0314M |
November 30, 2013 | 0.0285M |
August 31, 2013 | |
May 31, 2013 | |
February 28, 2013 | |
November 30, 2012 | |
August 31, 2012 | -0.3172M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (TTM) Range, Past 5 Years
-316.72M
Minimum
Nov 2020
332.57M
Maximum
Feb 2022
-72.36M
Average
-56.17M
Median
Cash from Investing (TTM) Benchmarks
Clever Leaves Holdings Inc | 4.694M |
Flora Growth Corp | -0.234M |
Acasti Pharma Inc | -1.452M |
Aurinia Pharmaceuticals Inc | -6.706M |
Edesa Biotech Inc | 0.00 |